These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24894544)

  • 1. Analysis of release kinetics of ocular therapeutics from drug releasing contact lenses: Best methods and practices to advance the field.
    Tieppo A; Boggs AC; Pourjavad P; Byrne ME
    Cont Lens Anterior Eye; 2014 Aug; 37(4):305-13. PubMed ID: 24894544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery.
    Xu J; Li X; Sun F
    Drug Deliv; 2011 Feb; 18(2):150-8. PubMed ID: 21043996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusting biomaterial composition to achieve controlled multiple-day release of dexamethasone from an extended-wear silicone hydrogel contact lens.
    Kaczmarek JC; Tieppo A; White CJ; Byrne ME
    J Biomater Sci Polym Ed; 2014; 25(1):88-100. PubMed ID: 24070140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow.
    Ali M; Horikawa S; Venkatesh S; Saha J; Hong JW; Byrne ME
    J Control Release; 2007 Dec; 124(3):154-62. PubMed ID: 17964678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular release of timolol from molecularly imprinted soft contact lenses.
    Hiratani H; Fujiwara A; Tamiya Y; Mizutani Y; Alvarez-Lorenzo C
    Biomaterials; 2005 Apr; 26(11):1293-8. PubMed ID: 15475059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Release of Antibiotics From Vitamin E-Loaded Silicone-Hydrogel Contact Lenses.
    Paradiso P; Serro AP; Saramago B; Colaço R; Chauhan A
    J Pharm Sci; 2016 Mar; 105(3):1164-72. PubMed ID: 26886333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses.
    Boone A; Hui A; Jones L
    Eye Contact Lens; 2009 Sep; 35(5):260-7. PubMed ID: 19657281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials.
    Korogiannaki M; Guidi G; Jones L; Sheardown H
    J Biomater Appl; 2015 Sep; 30(3):361-76. PubMed ID: 25887216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials.
    Hui A; Boone A; Jones L
    Eye Contact Lens; 2008 Sep; 34(5):266-71. PubMed ID: 18779666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Ciprofloxacin Release Using Vitamin E Diffusion Barrier From Commercial Silicone-Based Soft Contact Lenses.
    Shayani Rad M; Mohajeri SA
    Eye Contact Lens; 2017 Mar; 43(2):103-109. PubMed ID: 26863046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous drug delivery through the use of disposable contact lenses.
    Lesher GA; Gunderson GG
    Optom Vis Sci; 1993 Dec; 70(12):1012-8. PubMed ID: 8115123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid.
    Guidi G; Korogiannaki M; Sheardown H
    Eye Contact Lens; 2014 Sep; 40(5):269-76. PubMed ID: 25162288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow.
    Tieppo A; Pate KM; Byrne ME
    Eur J Pharm Biopharm; 2012 May; 81(1):170-7. PubMed ID: 22333489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible coils with a drug-releasing hydrophilic coating: a new platform for controlled delivery of drugs to the eye?
    Pijls RT; Hanssen HH; Nuijts RM; Koole LH
    Biomed Mater Eng; 2004; 14(4):383-93. PubMed ID: 15472387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of contact lens based ocular drug delivery systems for single-day use: Part (I) Structural factors, surrogate ophthalmic dyes and passive diffusion studies.
    Mahomed A; Tighe BJ
    J Biomater Appl; 2014 Sep; 29(3):341-53. PubMed ID: 24663443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of betamethasone from vitamin E-loaded silicone-based soft contact lenses.
    Rad MS; Sajadi Tabassi SA; Moghadam MH; Mohajeri SA
    Pharm Dev Technol; 2016 Nov; 21(7):894-899. PubMed ID: 26334597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses.
    Hsu KH; de la Jara PL; Ariyavidana A; Watling J; Holden B; Garrett Q; Chauhan A
    Curr Eye Res; 2015 Mar; 40(3):267-73. PubMed ID: 24833321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.